A Study to Examine the Safety of Different Doses of BG-68501 Given to Participants With Advanced-Stage Tumors
BeOne Medicines
BeOne Medicines
PrECOG, LLC.
GlaxoSmithKline
NiKang Therapeutics, Inc.
Bristol-Myers Squibb
AstraZeneca
National Institutes of Health Clinical Center (CC)
Seagen Inc.
Merck Sharp & Dohme LLC
Pfizer
Boehringer Ingelheim
Pfizer
Eli Lilly and Company
AstraZeneca
Pfizer
Amgen
Kivu Bioscience Inc.
Amgen
BioNTech SE
Astellas Pharma Inc
AbbVie
Merck Sharp & Dohme LLC
Henry Ford Health System
MediLink Therapeutics (Suzhou) Co., Ltd.
Big Ten Cancer Research Consortium
Molecular Partners AG
Exscientia AI Limited
Conjupro Biotherapeutics, Inc.
NRG Oncology
Guangdong Association of Clinical Trials
West China Hospital
Hunan Cancer Hospital
Sichuan Kelun Pharmaceutical Research Institute Co., Ltd.
Peking University First Hospital
Memorial Sloan Kettering Cancer Center
Instituto de Investigación Biomédica de Salamanca
UNC Lineberger Comprehensive Cancer Center
Medical University of South Carolina
SWOG Cancer Research Network
National Institutes of Health Clinical Center (CC)
Memorial Sloan Kettering Cancer Center
Tongji Hospital
Radiopharm Theranostics, Ltd
Novartis
National Institutes of Health Clinical Center (CC)
Avacta Life Sciences Ltd
Beijing Biotech
Zai Lab (Hong Kong), Ltd.
PMV Pharmaceuticals, Inc
VA Office of Research and Development